Sonic Healthcare Limited
SHL
Peringkat dalam Saham
#2841
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Harga Saham
$13.26
Kapitalisasi Pasar
$6.55B
Perubahan (1 hari)
-0.21%
Perubahan (1 tahun)
-4.48%
Negara
AU
Perdagangan Sonic Healthcare Limited (SHL)
Kategori
Healthcare
Laba untuk Sonic Healthcare Limited (SHL)
Laba pada Jun 2026 TTM: $581.53M
Menurut laporan keuangan terbaru dari Sonic Healthcare Limited, laba saat ini perusahaan adalah $581.53M. Pada tahun 2024, perusahaan memperoleh laba sebesar $487.85M, penurunan dibandingkan dengan laba tahun 2023 sebesar $620.44M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Sonic Healthcare Limited dari 2000 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $581.53M | 17.65% |
| 2025 | $494.30M | 1.32% |
| 2024 | $487.85M | -21.37% |
| 2023 | $620.44M | -56.70% |
| 2022 | $1.43B | 4.50% |
| 2021 | $1.37B | 184.25% |
| 2020 | $482.35M | -4.91% |
| 2019 | $507.24M | 11.00% |
| 2018 | $456.95M | 3.07% |
| 2017 | $443.36M | -0.42% |
| 2016 | $445.22M | 24.81% |
| 2015 | $356.72M | -26.56% |
| 2014 | $485.74M | 19.92% |
| 2013 | $405.04M | -5.17% |
| 2012 | $427.14M | 2.04% |
| 2011 | $418.61M | 27.85% |
| 2010 | $327.42M | 62.12% |
| 2009 | $201.96M | -36.56% |
| 2008 | $318.35M | 29.08% |
| 2007 | $246.63M | 25.90% |
| 2006 | $195.89M | 69.95% |
| 2005 | $115.26M | 60.97% |
| 2004 | $71.61M | 36.20% |
| 2003 | $52.57M | 41.85% |
| 2002 | $37.06M | 31.08% |
| 2001 | $28.27M | 16.52% |
| 2000 | $24.26M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $7.61B | 1,208.44% |
US
|
|
| $4.76B | 718.87% |
US
|
|
| $-252.70M | -143.45% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 185.11% |
US
|
